Press Releases about Incyte Corp![]()
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
February 05, 2024
From Incyte
Via Business Wire
![]() ![]()
Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
January 23, 2024
From Incyte
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Science Magazine Recognizes Incyte as #2 “Top Employer” of 2023
October 27, 2023
From Incyte
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|